王培東。2006。疾病發生的測量:發生率(Incidence)和盛行率(Prevalence)。台灣醫界。第49卷第4期。
下載日期:2016/08/16。
[ http://www.tma.tw/magazine/ShowRepID.asp?rep_id=2228 ]
王麗如。2006。台灣北部地區民眾對保健食品的認知、接受度及營養知識之探討。臺北醫學大學保健營養學系碩士學位論文。內政部戶政司全球資訊網。2016a。歷月人口統計資料。縣市人口數按性別及年齡。
下載日期:2017/05/07。
[ http://www.ris.gov.tw/346 ]
內政部戶政司全球資訊網。2016b。年度縣市及全國統計資料。十五歲以上人口按年齡及教育程度。
下載日期:2017/05/07。
[ http://www.ris.gov.tw/346 ]
台灣失智症協會。2016。認識失智症。
下載日期:2016/08/02。
[ http://www.tada2002.org.tw/tada_know_02.html ]
全民健康保險藥物給付項目及支付標準。(2013)。第六編第八十三條 「藥品給付規定」修正規定。
下載日期:2016/08/02。
[ http://www.nhi.gov.tw/Resource/bulletin/4628_修正規定.pdf ]
吳明隆。2004。SPSS 統計應用學習實務-問卷分析與應用實務。知城數位科技股份有限公司。台北。
許志成、熊昭、陳鴻鈞、黃秋錦、黃尚志、吳麥斯、簡麗年、林彥仲、高治圻。2016。2015台灣腎病年報。國家衛生研究院。2016年1月出版。1: 24。
陳暉雯。2010。妙用魚油護身大法。中國醫訊月刊。83:42-45。
陳靜君。2010。大台北地區中年人保健食品食用行為及其相關因素之研究。臺灣師範大學人類發展與家庭學系碩士學位論文。黃毓文。2004。補充n-3不飽和脂肪酸對阿茲海默症病患其延緩智能退化之效果評估。臺北醫學大學保健營養學系碩士學位論文。曾哲明。2015。免疫學。新文京開發出版股份有限公司。2015年1月修訂版再刷。
13, 416。
梁家欣、程蘊菁、陳人豪。2014。失智症之重點回顧。台大醫院老年醫學部內科學誌。25:151-157。下載日期:2016/08/02。
[ http://www.tsim.org.tw/journal/jour25-3/04.PDF ]
郭建宏。2014。從通路行銷看老年族群的保健市場。台灣老年學論壇。21:1-8。
楊智雅。2004。就診民眾對保健食品的食用風險認知與傳播影響。臺北醫學大學公共衛生學系碩士學位論文。廖英粟。2013。保健食品的購買行為之研究。淡江大學國際商學系碩士在職專班碩士學位論文。廖美智。2004。食品生技產業現況與趨勢。行政院農業委員會專題研究報告。
衛生福利部。2017。105年國人死因統計結果。
下載日期:2017/06/24。
[ http://www.mohw.gov.tw/news/572256044 ]
衛生福利部食品藥物管理署。2010。魚油會溶解保麗龍,是否因含有有機溶劑?發布日期:2010-02-03。
下載日期:2016/08/02。
[ http://www.fda.gov.tw/tc/faqContent.aspx?id=903&chk=2511b743-e172-4f14-a45
6-f0227752a8b7#.V6oGR1d9Lp0 ]
劉秀枝。2008。失智症的診斷、治療及預防。
下載日期:2016/08/16。
[ http://caregiver.pixnet.net/blog/post/15365814 ]
劉翠玲。2009。全球保健食品產業發展現況與展望。農業生技產業季刊。18:1-8。顏秀雯。2001。花錢買健康–探討健康食品消費真貌。國立台灣大學新聞研究所深度採訪報導碩士學位論文。Abeywardena, M.Y., & Head, R.J. (2001). Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Research, 52, 361–371.
Alhmosi, K., Selig, M., Sustic, T., Katrangi, E., Weissig, V., & Laposata, M. (2008). Induction of Apoptosis and Necrosis in Human Peripheral Blood Mononuclear Cells by Fatty acid Ethyl Esters. Alcoholism: Clinical and Experimental Research, 32, 534-543.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders, fifth edition. Washington, DC. American Psychiatric Press.
下載日期 : 2016/08/02.
[https://www.psychiatry.org/psychiatrists/practice/dsm/dsm-5]
Bang, H.O., Dyerberg, J., & Nielsen, A.B. (1971). Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet, 1, 1143–1145.
Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J.F., & Alpérovitch, A. (2007). Dietary patterns and risk of dementia: the Three-City cohort study. Neurology, 69, 1921 – 1930.
Bardena, A.E., Burkea, V., Masa, E., Beilina, L.J., Puddeya, I.B., Wattsa, G.F.,
Irishb, A.B., & Moria, T.A. (2015). n-3 fatty acids reduce plasma
20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease. Journal of Hypertension, 33, 1947-1953.
Bhopal, R.S. (2002). Concepts of Epidemiology. 1st ed. New York. Oxford University Press Inc. 166-188.
Birren, J.E., & Birren, B.A. (1990). Handbook of the psychology of aging 3rd ed. San Diego. Acaremic press. 3-20. ISBN 0121012808, 9780121012809.
Blankman, K., Ellenbogen, M., Graham, N., Hogg, L., Mittler, P., Piot, P., Splaine, M., Vernooij-Dassen, M., & Watt, A. (2012). Dementia: A Public Health Priority.
下載日期 : 10/10/2015.
[http://www.who.int/mental_health/publications/dementia_report_2012/]
Bonaa, K.H., Bjerve, K.S., Straume, B., Gram, I.T., & Thelle, D. (1990). Effect of
eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension: a population-based intervention trial from the Tromsø study. The New England Journal of Medicine, 322, 795– 801.
Boston, P.F., Bennett, A., Horrobin, D.F., & Bennett, C.N. (2004) Ethyl-EPA in Alzheimer’s disease-a pilot study. Prostaglandins Leukot Essent Fatty Acids, 71, 341–346.
Burke, G.L., & Carlson, M.C. (2005). Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology, 65, 1409–1414.
Brenna, J.T. (2002). Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Current Opinion Clinical Nutrition and Metabolic Care, 5, 127–132.
Calder, P.C. (2004). n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clinical Science, 107, 1–11.
Calviello, G., Serini, S., & Piccioni, E. (2008). Alzheimer’s disease and n-3 polyunsaturated fatty acids: beneficial effects and possible molecular pathways involved. Current Signal Transduction Therapy, 3, 152–157.
Cansev, M., & Wurtman, R.J. (2007). Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience, 148, 421 – 431.
Chen, S.Y., Lin, J.R., Kao, M.D., & Hang, C.M. (2005). The usage of dietary supplements among elderly individuals in Taiwan. Asia pacific Journal of clinical nutrition, 14, 230-237.
Cicero, A.F., Ertek , S., & Borghi, C. (2009). Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Current Vascular Pharmacology, 7, 330-337.
Cole, G.M., Ma, Q.L., & Frautschy, S.A. (2009). Omega-3 fatty acids and dementia. Prostaglandins Leuko Essent Fatty Acids, 81, 213 – 221.
Conklin, S.M., Gianaros, P.J., Brown, S.M., Yao, J.K., Hariri, A.R., Manuck, S.B., & Muldoon, M.F. (2007). Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neuroscience Letters, 421, 209 – 212.
Cunnane, S.C., Plourde, M., Pifferi, F., Féart, C., & Barberger-Gateau, P. (2009). Fish, docosahexaenoic acid and Alzheimer’s disease. Progress in Lipid Research, 4, 239–256.
David, J.K. (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC. American Psychiatric Association, 591-644.
Dunstan, J.A., Mori, T.A., Barden, A., Bellin, L.J., Taylor, A.L., Holt, P.G., & Prescott, S.L. (2003). Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. The Journal of Allergy Clinical Immunology, 112, 1178 – 1184.
D'Vaz, N., Meldrum, S.J., Dunstan, J.A., Lee-Pullen, T.F., Metcalfe, J., Holt, B.J., Serralha, M., Tulic, M.K., Mori, T.A., & Prescott, S.L. (2012). Fish oil supplementation in early infancy modulates developing infant immune responses. Clinical and Experimental Allergy, 42, 1206 – 1216.
Engel, J.F., Blackwell, R.D., & Miniard, P.W. (1995). Consumer Behavior 8th ed., Orlando, Dryden Press.
Engel, J.F., Kollat, D., & Blackwell, R.D. (1982). Consumer Behavior 4th ed., Taipei, Hwa-Tai Co.
Fassett, R.G., Gobe, G.C., Peake, J.M., & Coombes, J.S. (2010). Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. American Journal of Kidney Diseases, 56, 728–742.
Fearon, K.C., Barber,M.D., Moses, A.G., Ahmedzai, S.H., Taylor, G.S., Tisdale, M.J., & Murray, G.D. (2006). Double-Blind, Placebo-Controlled, Randomized study of Eicosapentaenoic Acid Diester in Patiens With Cancer Cachexia. Journal of Clinical Oncology, 24, 3401-3407.
Florent-Bechard, S., Malaplate-Armand, C., Koziel, V., Kriem, B., Olivier, J.L., Pillot, T., & Oster, T. (2007).Towards a nutritional approach for prevention of Alzheimer’s disease: biochemical and cellular aspects. Journal of the Neurological Sciences, 262, 27–36.
Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal Psychiatric Research,12, 189 – 198.
Fontani, G., Corradeschi, F., Felici, A., Alfatti, F., Migliorini, S., & Lodi. L. (2005). Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. European Journal of Clinical Investigation, 35, 691–699.
Fotuhi, M., Mohassel, P., & Yaffe, K. (2009). Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nature Reviews Neuroogy, 5, 140 – 152.
Friborg, J.T., & Melbye, M. (2008). Cancer patterns in Inuit populations. The Lancet Oncologe, 9, 892 – 900.
Gaudard, A., Varlet-Marie, E., Bressolle, F., Mercier, J., & Brun, J.F. (2004). Nutrition as a Determinant of blood rheology and fibrinogen in althletes. Clinical Hemorheology and Microcirculation, 30, 1-8.
Gomez-Pinilla, F. (2008). Brain foods: the effects of nutrients on brain function. Nature Reviews Neuroscience, 9, 568 – 578.
Gopinath, B., Harris, D.C., Flood, V.M., Burlutsky, G., & Mitchell, P. (2011).
Consumption of long-chain n-3 PUFA, a-linolenic acid and fish is associated with the prevalence of chronic kidney disease. British Journal of Nutrition, 105, 1361–1368.
Gu, Y., Schupf, N., Cosentino, S.A., Luchsinger, J.A., & Scarmeas, N. (2012). Nutrient intake and plasma beta-amyloid. Neurology, 78, 1832 – 1840.
Guezennec, C.Y., Nadaud, J.F., Satabin, P.,Leger, F., & Lafargue, P. (1989). Influence of polyunsaturated fatty acid diet on the hemorrheological response to physical exercise in hypoxia. Inernational Journal of Sports Medicine, 10, 286-291.
Haber, P.S., Wilson, J.S., Apte, M.V., & Pirola, R.C. (1993). Fatty acid ethyl esters increase rat pancreatic lysosomal fragility. The Journal of Laboratory and Clinical Medicine, 121, 759-764.
Han, H., Yun, Y., Kim, G., Lee, Y.H., Wang, H.J., Lee, B.W., Cha, B.S., Kim, B.S., & Kang, E.S. (2015). Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia. PLOS One, 11, e 0154683. doi :10.1371/journal.pone.0154683.
Hanne, K.M., Ida-Johanne, J., Edel, O.E., & Karl-Erik, E. (2015). ω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary Relevance. International Journal of Molecular Science,16, 22636-22661.
Harris, W.S. (1997). n-3 fatty acids and serum lipoprotein: human studies. The American Journal of Clinical Nutrition, 65, 1645S – 1654S.
Harrison, R.A., Holt, D., Pattison, D.J., & Elton, P.J. (2004). Are those in need taking dietary supplements? A survey of 21923 adults. The British Journal of Nutrition, 91, 617-623.
Harwell, S,E., & Driskell, J.A. (2000). Ethnicity of Caucasian Adults Influences Vitamin/mineral Usage. Journal of Family and Consumer Sciences, 92, 52-57.
Heude, B., Ducimetiere, P., & Berr, C. (2003). Cognitive decline and fatty acid composition of erythrocyte membranes: the EVA Study. The American Journal of Clinical Nutrition, 77, 803– 808.
Hoogeveen, E.K., Geleijnse, J.M., Kromhout, D., Stijnen, T., Gemen, E.F., Kusters, R., & Giltay, E.J. (2014). Effect of Omega-3 Fatty Acids on Kidney Function after Myocardial Infarction: The Alpha Omega Trial. Clinical Journal of the American Society of Nephrology, 9, 1676-1683.
Hoogeveen, E.K., Halbesma, N., Rothman, K.J., Stijnen, T., van Dijk, S., Dekker, F.W., Boeschoten, E.W., & de Mutsert, R. (2012). Netherlands Cooperative Study on the Adequacy of Dialysis-2 (NECOSAD) Study Group: Obesity and mortality risk among younger dialysis patients. Clinical Journal of the American Society of Nephrology, 7, 280–288.
Hooijmans, C.R., Pasker-de Jong, P.C.M., de Vries, R.B.M., & Ritskes-Hoitinga, M. (2012). The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer’s pathology in animal models of Alzheimer’s disease: a systematic review and meta-analysis. Journal of Alzheimers Disease, 28, 191 – 209.
Huang, T.L., Zandi, P.P., Tucker, K.L., Fitzpatrick, A.L., Kuller, L.H., Fried, L.P., Kalmijn, S., van Boxtel, M.P., Ocke, M., Verschuren, W.M., Kromhout, D., & Launer, L.J. (2004). Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology, 62, 275–280.
Kannel, W.B., Belanger, A., D’Agostino, R., & Israel, I. (1986). Physical activity and physical demand on the job and risk of cardiovascular disease and death: the Framingham Study. American Heart Journal, 112, 820 – 825.
Kaur, K., Harris, S.G., Padilla, J., Graf, B.A., & Phipps, R.P. (1999). Prostaglandin E2 as a Modulator of lymphocyte mediated inflammatory and humoral responses. Advances in Experimental Medicine and Biology, 469, 409 – 412.
Kawakita, E., Hashimoto, M., & Shido, O. (2006). Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience, 139, 991–997.
Keli, S.O., Feskens, E.J., & Kromhout, D. (1994). Fish consumption and risk of stroke: The Zutphen Study. Stroke, 25, 328–332.
Kelley, D.S., Siegel, D., Vemuri, M., Chung, G.H., & Mackey, B.E. (2008). Docosahexaenoic acid supplementation decreases remnant-like particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men. The Journal of Nutrition, 138, 30–35.
Kotler, P. (1998). Marketing Management: Analysis, Planning, Implementation and Control 9th ed, Prentice-Hall.
Kotler, P., & Amstrong, G. (2001). Marketing management Analysis, Planning Implementation and Control, 9th, New Jersey, Prentice Hall.
Kromhout, D., Yasuda, S., Geleijnse, J.M., & Shimokawa, H. (2012). Fish oil and omega-3 fatty acids in cardiovascular disease: Do they really work? European Heart Journal, 33, 436–443.
Kronborg, J., Solbu, M., Njølstad, I., Toft, I., Eriksen, B.O., & Jenssen, T. (2008). Predictors of change in estimated GFR: A population-based 7-year follow-up from the Tromso study. Nephrology Dialysis Transplantation, 23, 2818–2826.
Lauretani, F., Semba, R.D., Bandinelli , S., Miller, E.R., Ruggiero, C., Cherubini, A., Guralnik, J.M., & Ferrucci, L. (2008). Plasma polyunsaturated fatty acids and the decline of renal function. Clinical Chemistry, 54, 475 – 481.
Lawson, L.D., & Hughes, B.G. (1988). Human absorption of fish oil fatty acids as
triacylglycerols, free acids, or ethyl esters. Biochemical and Biophysical Research Communications, 152, 328-335.
Lee, L.K., Shahar, S., Chin, A.V., & Yusoff, N. A. M. (2013). Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology, 225, 605 – 612.
Li, J., Xun, P., Zamora, D., Sood, A., Liu, K., Daviglus, M., Irbarren, C., Jacobs, D.Jr., Shikany, J.M., & He, K. (2013). Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. The American Journal of Clinical Nutrition, 97, 173 – 178.
Lowin, A., Knapp, M., & McCrone, P. (2001). Alzheimer’s disease in the UK: comparative evidence on cost of illness and volume of health servicesresearch funding. International Journal of Geriatric Psychiatry, 16:1143–1148.
Ma, Y.H. (1994). Schwartzman ML, Roman RJ. Altered renal P-450 metabolism of
arachidonic-acid in dahl salt-sensitive rats. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 267, R579 – R589.
Macpherson, H., Ellis, K.A., Sali, A., & Pipingas, A. (2012). Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement. Psychopharmacology, 220, 351 – 365.
Mansara, P., Ketkar, M., Deshpande1, R., Chaudhary, A., Shinde., K. & Ghanekar, R.K. (2015). Improved antioxidant status by omega-3 fatty acid supplementation in breast cancer patients undergoing chemotherapy: a case series. Journal of Medical Case Reports, 9, 148.
Mas, E., Barden, A., Durand, T., Galano, J.M., Croft, K.D., & Mori, T.A. (2010).
Measurement of urinary F-2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances. Free Radical Research, 44, 191–198.
Moore, S.A., Yoder, E., Murphy, S., Dutton, G.R., & Spector, A.A. (1991). Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). Journal of Neurochemistry, 56, 518–524.
Palmer, D.J., Sullivan, T., Gold, M.S., Prescott, S.L., Heddle, R., Gibson, R.A., &
Makrides, M. (2012). Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants’ allergies in first year of life: randomised controlled trial. The BMJ, 344.
[http://dx.doi.org/10.1136/bmj.e184].
Petersen, R.C. (2007). Mild cognitive impairment. Continuum Lifelong Learning in Neurology, 13, 15 – 38.
Pomponi, M. (2008). DHA deficiency and Alzheimer’s disease. Clinical Nutrition, 27,170.
Quinn, J.F., Raman, R., Thomas, R.G.,Yurko-Mauro, K., Nelson, E.B.,Van Dyck, C., Galvin, J.E., Emond, J., Jack, C.R., Weiner, M., Shinto, L., & Aisen, P.S. (2010). Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA, 304, 1903–1911.
Reddy, M.A., Tak Park, J., & Natarajan, R. (2013)Epigenetic modifications in the
pathogenesis of diabetic nephropathy. Seminars in Nephrology, 33, 341–353.
Rey, A. (1964). L’examen clinique en psychologie. In: Presses Universitaires de France. Paris (in French).
Roman, R.J. (2002). P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiological Reviews, 82, 131–185.
Sastry, P.S. (1985). Lipids of nervous tissue: composition and metabolism. Progress in Lipid Research, 24, 69-176.
Schmidt, E.B., Nieisen, L.K., Pedersen, J.O., Komerup, H.J., & Dyerberg, J. (1990). The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension. Clinica Chimica Acta, 189, 25-32.
Scholey, A., Ossoukhova, A., Owen, L., Ibarra, A., Pipingas, A., He, K.,Roller, M., & Stough,C. (2010). Effects of American ginseng (Panaxquinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology, 212, 345 – 356.
Sheikh, J.I., & Yesavage, J.A. (1986). GeriatricDepression Scale: recent evidence and development of a shorter version. Clinical Gerontologist, 5, 165 – 173.
Simopoulos, A.P. (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56, 365-379.
Sonobe, N., Hata, R., Ishikawa, T., Sonobe, T., Matsumoto, T., Toyota, Y., Mori, T., Fukuhara, R., Komori, K., Ueno, S.I., Tanimukai, S., & Ikeda, M. (2011). Risk of progression from mild memory impairment to clinically diagnosable Alzheimer’s disease in a Japanese community (from the Nakayama Study). International Psychogeriatrics, 23, 772 – 779.
Su, H.M. (2010). Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance neuroprotection. The Journal Nutritional Biochemistry, 21, 364 – 373.
Sunderland, T., Hill, J.L., Mellow, A.M., Lawlor, B.A., Gundersheimer, J., Newhouse, P.A., & Grafman, J.H. (1989). Clock drawing in Alzheimer’s disease: a novel measure of dementia severity. Journal of the Americam Geriatrics Society, 37, 725 – 729.
Tan, Z.S., Harris, W.S., Beiser, A. S., Au, R., Himali, J.J., Debette, S., Pikula, A., Decarli, C., Wolf, P.A., Vasan, R.S., & Robins, M.D. (2012). Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology, 78, 658 – 664.
The EFSA Journal (EFSA). (2009). Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the Commission related to labeling reference intake values for n-3 and n-6 polyunsaturated fatty acids. 1176, 1-11.
[ https://www.efsa.europa.eu/en/efsajournal/pub/1176 ]
The World Health Organization (WHO). (2003). Diet nutrition and the prevention of chronic diseases. Report of the WHO/ FAO Joint Expert Consultation, WHO, Technical Report Series 916.
Thorwest, M., Balling, E., Kristensen, S.D., Aagaard, S., Hakami, A., Husted, S.E., Marqversen, J., & Hjortdal, V.E. (2000). Dietary fish oil reduces microvascular thrombosis in a porcine experimental model. Throbosis Research, 99, 203-208.
Tur, J.A., Bibiloni, M.M., Sureda, A., & Pons, A. (2012). Dietary sources of omega 3 fatty acid: Public health risks and benefits. British Journal of Nutrition, 107, S23–S52.
van den Elsen, L.W., Nusse, Y., Balvers, M., Redegeld, F.A., Knol, E.F., Garssen, J., & Willemsen, L.E. (2012). n-3 Long-chain PUFA reduce allergy-related mediator release by human mast cells in vitro via inhibition of reactive oxygen species. British Journal of Nutrition, 109, 1–11.
van den Elsen, L.W., van Esch, B.C., Hofman, G.A., Kant, J., van de Heijning, B.J., Garssen, J., & Willemsen, L.E. (2013). Dietary long chain n-3 polyunsaturated fatty acids prevent allergic sensitization to cow's milk protein in mice. Clinical and Experimental Allergy, 43, 798 – 810.
Viswanathan, A., Rocca, W.A., & Tzourio, C. (2009). Vascular risk factors and dementia: how to move forward? Neurology, 72, 368 –374.
Walters, C.G., & Paul, W.G. (1970). Consumer Behaviors: an Integrated Framework, Homewood, III, Richard D. Irwin Inc. pp. 7.
Wechsler, D. (1984). Wechsler memory scale - revised manual. The Psychological Co, New York.
Wechsler, D. (1997). Wechsler adult intelligence scale. Harcourt Assessment, London.
Wetzels, J.F., Kiemeney, L.A., Swinkels, D.W., Willems, H.L., & den Heijer, M. (2007). Age-and gender-specific reference values of estimatedGFR in Caucasians: The Nijmegen Biomedical Study. Kidney International, 72, 632–637.
Whalley, L.J., Deary, I.J., Starr, J.M., Wahle, K.W., Rance, K.A., Bourne, V.J., & Fox, H.C. (2008). n-3 Fatty acid erythrocyte membrane content, APOE epsilon4, and cognitive variation: an observational followup study in late adulthood. The American Journal of Clinical Nutrition, 87, 449–454.
Wimo, A., & Prince, M. (2010). World Alzheimer Report, The Global Economic Impact of Dementia.
下載日期 : 10/10/2015.
[ http://www.alz.co.uk/research/files/WorldAlzheimerReport2010.pdf ]
Witte, A.V., Kerti, L., Hermannstadter, H.M., Fiebach, J.B., Schreiber, S.J., Schuchardt, J.P., Hahn, A., & Floel, A. (2014). Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults. Cerebral Cortex, 24, 3059 – 3068.
Worsley, A., & Scott, V. (2000). Consumers’ concerns about food and health in Australia and New Zealand, Asia Pacific Journal Clinical Nutrition, 9, 24-32.
Xu, F.Y., Straub, W.O., Pak, W., Su, P., Maier, K.G., Yu, M., Roman, R.J., Ortiz De Montellano, P.R., & Kroetz, D.L. (2002). Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid ω-hydroxylase activity. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 283, R710–R720.
Yates, C.M., Calder, P.C., & Ed, R.G. (2014). Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacology Therapeutics, 141, 272 – 281.
Zheng, J.S., Hu, X.J., Zhao, Y.M., Yang, J., & Li, D. (2013). Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. The BMJ, 346 (f3706), 12.